Skip to content
Home/Companies/Biotech/Aptadir Therapeutics

Aptadir Therapeutics

Biotech·Italy·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Aptadir Therapeutics?

Aptadir Therapeutics is an Italian Biotech company, currently owned by 4Bio Partners since 2026.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
4Bio Partners
Investor
4Bio Partners
4BIO Ventures III · 2022 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cloverleaf Bio
Active
BiotechUnited States· 2026
Cytospire Therapeutics
Cytospire Therapeutics
Active
BiotechUK· 2026
Actithera
Actithera
Active
BiotechSwitzerland· 2025
Hornet Therapeutics
Active
BiotechUK· 2024
March Biosciences
March Biosciences
Active
BiotechUS· 2024
Ascend Advanced Therapies
Ascend Advanced Therapies
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Aptadir Therapeutics?

Aptadir Therapeutics is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2026.

When did 4Bio Partners acquire Aptadir Therapeutics?

4Bio Partners acquired Aptadir Therapeutics in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue